Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Rybelsus
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rybelsus 7mg tablets
0601023AWBCACAF
|
Rybelsus | Semaglutide | Endocrine System | 58,626 |
|
Rybelsus 14mg tablets
0601023AWBCAAAD
|
Rybelsus | Semaglutide | Endocrine System | 48,362 |
|
Rybelsus 3mg tablets
0601023AWBCABAE
|
Rybelsus | Semaglutide | Endocrine System | 27,709 |
|
Rybelsus 1.5mg tablets
0601023AWBCADAK
|
Rybelsus | Semaglutide | Endocrine System | No data available |
|
Rybelsus 4mg tablets
0601023AWBCAEAL
|
Rybelsus | Semaglutide | Endocrine System | No data available |
|
Rybelsus 9mg tablets
0601023AWBCAFAM
|
Rybelsus | Semaglutide | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.